Co-Diagnostics (CODX) Misses Q1 EPS by 10c

Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'